Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAIN-AD
2007-004897-26Phase 4Completed
- Sponsor
- King's College London
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of memantine in Alzheimer's disease (AD) (2 arms), sponsored by King's College London. Primary endpoint: Activities of daily living. Started Mar 2008; status: completed.
02
Drugs
memantine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2007-004897-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004897-26.